| Name | Title | Contact Details |
|---|
Innoviti started its payments business in 2008 and quickly established itself as a pioneer in using technology to solve real-world payment problems for merchants. Using its indigenously developed and patented payments platform, Innoviti has delivered i...
control freaks is a Beaverton, OR-based company in the Software and Internet sector.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Affinity is an ad tech company which creates user engagement products (branding and performance) for digital media while paying special attention to user experience.
CORAS transforms how DoD leaders make decisions in planning, budgeting military assets & programs with its Enterprise Decision Management Platform (EDMP).